Name : Mr.

MOHAMMED SHIFUL IOSLAM Member Id : Validated : 03-12-2021 01:56

Age : 32 Y / M Visit No : A01O21120004295 Reported : 03-12-2021 01:58

/Sex
MR No : UA0100000068229 Referred : SELF Printed On : 03-12-2021 03:10
By
EID : 784-1989-3819813-6
Passport: EB0611150 Unified ID
Laboratory Report

Microbiology

Test Description Result Units Reference Range

Coronavirus Disease (Covid-2019), PCR

NOTE: The SARS-CoV-2 assay is a RT-
PCR test intended for the qualitative
detection of nucleic acid from the
SARS-CoV-2 in respiratory specimens .
Positive results are indicative of the
presence of SARS-CoV-2 RNA; clinical
correlation with patient history and
other diagnostic information is
necessary to determine patient
infection status. Negative results do
not preclude SARS-CoV-2 infection
and should not be used as the sole
basis for patient management
decisions.
Sampled:02-12-2021 16:35
Assertion Date & Time:02-12-2021 17:52
Novel Coronavirus (2019-nCoV), PCR Not Not Detected
[Not accredited under ISO15189]
Methodology: RT-PCR Sars-CoV2 ORF, N Genes Detected
Perf.Center - NMCAbuDhabi

*** END OF REPORT ***

Signed and approved electronically on 03-12-2021 01:58. For further information please contact your doctor.
On 27 September 2020 a number of the entities of the NMC Healthcare group were placed into administration under Abu Dhabi Global Market Regulations. Richard
Fleming and Ben Cairns have been appointed Joint Administrators in this regard to manage the affairs, business and property of the relevant companies in
administration as agents without personal liability. In that capacity the Joint Administrators have delegated certain powers to the board of directors to act as agents
of the relevant companies. For full information regarding these appointments please redirect to this web page: https://nmc.ae/
Page 1 of 1